SPECT/CT imaging of lung cancers with 99mTc‐HYNIC‐αLAG‐3 and 99mTc‐HYNIC‐αPD‐L1 probes represents an effective method for noninvasively visualizing LAG‐3 and PD‐L1, and immunotherapy resistance monitoring. Here, CD274 is linked to lung carcinoma.